A citation-based method for searching scientific literature

Kinga I Gawlik, Madeleine Durbeej. Skelet Muscle 2011
Times Cited: 72







List of co-cited articles
699 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy.
Jachinta E Rooney, Jolie R Knapp, Bradley L Hodges, Ryan D Wuebbles, Dean J Burkin. Am J Pathol 2012
68
33

Laminin alpha2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy.
Y Miyagoe, K Hanaoka, I Nonaka, M Hayasaka, Y Nabeshima, K Arahata, Y Nabeshima, S Takeda. FEBS Lett 1997
203
30

Laminin alpha1 chain reduces muscular dystrophy in laminin alpha2 chain deficient mice.
Kinga Gawlik, Yuko Miyagoe-Suzuki, Peter Ekblom, Shin'ichi Takeda, Madeleine Durbeej. Hum Mol Genet 2004
101
29

Autophagy is increased in laminin α2 chain-deficient muscle and its inhibition improves muscle morphology in a mouse model of MDC1A.
Virginie Carmignac, Martina Svensson, Zandra Körner, Linda Elowsson, Cintia Matsumura, Kinga I Gawlik, Valerie Allamand, Madeleine Durbeej. Hum Mol Genet 2011
90
29

Losartan, a therapeutic candidate in congenital muscular dystrophy: studies in the dy(2J) /dy(2J) mouse.
Moran Elbaz, Nurit Yanay, Shlomit Aga-Mizrachi, Zivia Brunschwig, Ibaa Kassis, Keren Ettinger, Vivian Barak, Yoram Nevo. Ann Neurol 2012
54
38

Omigapil ameliorates the pathology of muscle dystrophy caused by laminin-alpha2 deficiency.
Michael Erb, Sarina Meinen, Patrizia Barzaghi, Lazar T Sumanovski, Isabelle Courdier-Früh, Markus A Rüegg, Thomas Meier. J Pharmacol Exp Ther 2009
63
30



Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models.
W Kuang, H Xu, P H Vachon, L Liu, F Loechel, U M Wewer, E Engvall. J Clin Invest 1998
152
25

Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy.
A Helbling-Leclerc, X Zhang, H Topaloglu, C Cruaud, F Tesson, J Weissenbach, F M Tomé, K Schwartz, M Fardeau, K Tryggvason. Nat Genet 1995
512
25

Proteasome inhibition improves the muscle of laminin α2 chain-deficient mice.
Virginie Carmignac, Ronan Quéré, Madeleine Durbeej. Hum Mol Genet 2011
47
36

An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy.
J Moll, P Barzaghi, S Lin, G Bezakova, H Lochmüller, E Engvall, U Müller, M A Ruegg. Nature 2001
176
23

Apoptosis inhibitors and mini-agrin have additive benefits in congenital muscular dystrophy mice.
Sarina Meinen, Shuo Lin, Raphael Thurnherr, Michael Erb, Thomas Meier, Markus A Rüegg. EMBO Mol Med 2011
35
45


Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy.
Mahasweta Girgenrath, Janice A Dominov, Christine A Kostek, Jeffrey Boone Miller. J Clin Invest 2004
96
20

Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations.
Fatemeh Geranmayeh, Emma Clement, Lucy H Feng, Caroline Sewry, Judith Pagan, Rachael Mein, Stephen Abbs, Louise Brueton, Anne-Marie Childs, Heinz Jungbluth,[...]. Neuromuscul Disord 2010
100
20

Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy.
Mahasweta Girgenrath, Mary Lou Beermann, Vivek K Vishnudas, Sachiko Homma, Jeffrey Boone Miller. Ann Neurol 2009
62
22

Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy.
P H Vachon, H Xu, L Liu, F Loechel, Y Hayashi, K Arahata, J C Reed, U M Wewer, E Engvall. J Clin Invest 1997
170
19




Diagnostic approach to the congenital muscular dystrophies.
Carsten G Bönnemann, Ching H Wang, Susana Quijano-Roy, Nicolas Deconinck, Enrico Bertini, Ana Ferreiro, Francesco Muntoni, Caroline Sewry, Christophe Béroud, Katherine D Mathews,[...]. Neuromuscul Disord 2014
177
18

Quantitative proteomic analysis reveals metabolic alterations, calcium dysregulation, and increased expression of extracellular matrix proteins in laminin α2 chain-deficient muscle.
Bruno Menezes de Oliveira, Cintia Y Matsumura, Cibely C Fontes-Oliveira, Kinga I Gawlik, Helena Acosta, Patrik Wernhoff, Madeleine Durbeej. Mol Cell Proteomics 2014
25
52


Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages.
Sarina Meinen, Patrizia Barzaghi, Shuo Lin, Hanns Lochmüller, Markus A Ruegg. J Cell Biol 2007
58
20



IGF-1/GH axis enhances losartan treatment in Lama2-related muscular dystrophy.
Anthony Accorsi, Ajay Kumar, Younghwa Rhee, Alex Miller, Mahasweta Girgenrath. Hum Mol Genet 2016
18
66


Distinct roles for laminin globular domains in laminin alpha1 chain mediated rescue of murine laminin alpha2 chain deficiency.
Kinga I Gawlik, Mikael Akerlund, Virginie Carmignac, Harri Elamaa, Madeleine Durbeej. PLoS One 2010
32
34



Dystrophin protects the sarcolemma from stresses developed during muscle contraction.
B J Petrof, J B Shrager, H H Stedman, A M Kelly, H L Sweeney. Proc Natl Acad Sci U S A 1993
15

Laminin alpha1 chain mediated reduction of laminin alpha2 chain deficient muscular dystrophy involves integrin alpha7beta1 and dystroglycan.
Kinga I Gawlik, Ulrike Mayer, Kristina Blomberg, Arnoud Sonnenberg, Peter Ekblom, Madeleine Durbeej. FEBS Lett 2006
46
23


Dysregulation of matricellular proteins is an early signature of pathology in laminin-deficient muscular dystrophy.
Thomas Mehuron, Ajay Kumar, Lina Duarte, Jenny Yamauchi, Anthony Accorsi, Mahasweta Girgenrath. Skelet Muscle 2014
20
55

Bortezomib partially improves laminin α2 chain-deficient muscular dystrophy.
Zandra Körner, Cibely C Fontes-Oliveira, Johan Holmberg, Virginie Carmignac, Madeleine Durbeej. Am J Pathol 2014
22
50

Laminin alpha2 deficiency and muscular dystrophy; genotype-phenotype correlation in mutant mice.
L T Guo, X U Zhang, W Kuang, H Xu, L A Liu, J-T Vilquin, Y Miyagoe-Suzuki, S Takeda, M A Ruegg, U M Wewer,[...]. Neuromuscul Disord 2003
63
15

Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix.
O Ibraghimov-Beskrovnaya, J M Ervasti, C J Leveille, C A Slaughter, S W Sernett, K P Campbell. Nature 1992
13


Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy.
Pam M Van Ry, Priscilla Minogue, Bradley L Hodges, Dean J Burkin. Hum Mol Genet 2014
45
22

Laminin α2 Chain-Deficiency is Associated with microRNA Deregulation in Skeletal Muscle and Plasma.
Johan Holmberg, Azra Alajbegovic, Kinga Izabela Gawlik, Linda Elowsson, Madeleine Durbeej. Front Aging Neurosci 2014
22
45

Omigapil treatment decreases fibrosis and improves respiratory rate in dy(2J) mouse model of congenital muscular dystrophy.
Qing Yu, Arpana Sali, Jack Van der Meulen, Brittany K Creeden, Heather Gordish-Dressman, Anne Rutkowski, Sree Rayavarapu, Kitipong Uaesoontrachoon, Tony Huynh, Kanneboyina Nagaraju,[...]. PLoS One 2013
28
35


Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies.
B L Hodges, Y K Hayashi, I Nonaka, W Wang, K Arahata, S J Kaufman. J Cell Sci 1997
153
12

The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review.
K J Jones, G Morgan, H Johnston, V Tobias, R A Ouvrier, I Wilkinson, K N North. J Med Genet 2001
104
12

Laminin-111 restores regenerative capacity in a mouse model for alpha7 integrin congenital myopathy.
Jachinta E Rooney, Praveen B Gurpur, Zipora Yablonka-Reuveni, Dean J Burkin. Am J Pathol 2009
55
16

Laminin-211 in skeletal muscle function.
Johan Holmberg, Madeleine Durbeej. Cell Adh Migr 2013
73
12

Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
Mariko Taniguchi, Hiroki Kurahashi, Satoru Noguchi, Jun Sese, Takeshi Okinaga, Toshifumi Tsukahara, Pascale Guicheney, Keiichi Ozono, Ichizo Nishino, Shinichi Morishita,[...]. Biochem Biophys Res Commun 2006
25
36

Triggering regeneration and tackling apoptosis: a combinatorial approach to treating congenital muscular dystrophy type 1 A.
Jenny Yamauchi, Ajay Kumar, Lina Duarte, Thomas Mehuron, Mahasweta Girgenrath. Hum Mol Genet 2013
17
52


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.